Not Signed In -
Heroin |
|
|
Clinical Trial: Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
This study has been completed.
Purpose
The purpose of this study is to assess the safety and effectiveness of buprenorphine for treatment of concurrent intravenous heroin and cocaine dependence.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Cocaine-Related Disorders Heroin Dependence | Drug: Buprenorphine | Phase II |
MedlinePlus related topics: Cocaine Abuse; Heroin Abuse
Study Type: Interventional
Study Design: Treatment, Uncontrolled
Official Title: Treatment Efficacy for Drug Abuse and AIDS Prevention
Eligibility
Ages Eligible for Study: 26 Years - 41 Years, Genders Eligible for Study: Male
Criteria
Please contact site for information.
Location Information
Massachusetts
McLean Hospital, Dept. of Psychiatry, Belmont, Massachusetts, 2178, United States
Study chairs or principal investigators
Jack Mendelson, M.D., Principal Investigator, Mclean Hospital
More Information
Study ID Numbers: NIDA-06116-1; R18-06116-1
Record last reviewed: December 2002
Last Updated: December 3, 2004
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000210
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: December 2002
Last Updated: December 3, 2004
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000210
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Heroin (Cleveland Clinic)
- Heroin: Abuse and Addiction (Cleveland Clinic)
email this page
print this page
bookmark this page
feedback on this page
